SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-09-001826
Filing Date
2009-03-18
Accepted
2009-03-18 17:24:57
Documents
10
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 RXI PHARMACEUTICALS CORPORATION b73473rxe10vk.htm 10-K 815807
2 EX-10.22 EMPLOYMENT AGREEMENT DATED OCTOBER 17, 2008 b73473rxexv10w22.htm EX-10.22 81809
3 EX-10.23 EMPLOYMENT AGREEMENT DATED NOVEMBER 10, 2008 b73473rxexv10w23.htm EX-10.23 47188
4 EX-23.1 CONSENT OF BDO SEIDMAN LLP b73473rxexv23w1.htm EX-23.1 1802
5 EX-31.1 CERTIFICATION OF THE CEO b73473rxexv31w1.htm EX-31.1 8076
6 EX-31.2 CERTIFICATION OF THE CFO b73473rxexv31w2.htm EX-31.2 8353
7 EX-32.1 CERTIFICATION OF THE CEO & CFO b73473rxexv32w1.htm EX-32.1 3835
8 GRAPHIC b73473rxb7347304.gif GRAPHIC 6997
9 GRAPHIC b73473rxb7347305.gif GRAPHIC 2602
10 GRAPHIC b73473rxb7347306.gif GRAPHIC 10297
  Complete submission text file 0000950135-09-001826.txt   996083
Mailing Address 60 PRESCOTT STREET WORCESTER MA 01605
Business Address 60 PRESCOTT STREET WORCESTER MA 01605 508-767-3861
RXI PHARMACEUTICALS CORP (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000
Type: 10-K | Act: 34 | File No.: 001-33958 | Film No.: 09691663
SIC: 2834 Pharmaceutical Preparations